MNOV MediciNova, Inc.

6.05
+0.01  (0%)
Previous Close 6.04
Open 6.02
Price To book 6.37
Market Cap 208.97M
Shares 34,540,000
Volume 63,711
Short Ratio 52.51
Av. Daily Volume 40,457

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2b final data due 2H 2017.
MN-166
Progressive multiple sclerosis (progressive MS)
Phase 2 planned
MN-001
NASH (nonalcoholic steatohepatitis)
Phase 2 data released August 2014
MN-166
Opioid dependence
Phase 2 interim data released April 2016
MN-166
Amyotrophic lateral sclerosis (ALS)